Evaluation of von Willebrand factor-cleaving protease activity in patients with thrombotic thrombocytopenic purpura
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 6
- DOI:
- No doi available
- Key Word:
- von Willebrand factor;cleaving protease;collagen binding assay;thrombotic thrombocytopenic purpura;tumor
Abstract： Background Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy. In this study we investigated the von Willebrand factor-cleaving protease (vWF-cp) activity deficiency in patients with TTP.Methods The plasma or serum vWF-cp activity was measured using a sensitive enzyme-linked immunosorbent assay (ELISA) by detecting the residual collagen binding activity (R-CBA) of von Willebrand factor (vWF) before and after digestion by vWF-cp. Multimers of vWF in plasma of patients with TTP were also analyzed by SDS-agarose electrophoresis. Moreover, the serum vWF-cp activities were compared between the patients with TTP and those with tumors.Results The coefficient of variation for intra-batch and inter-batch of the assay were 3.60% and 8.35%. The plasma and serum vWF-cp activity in healthy individuals were (78.79±9.17)% (n=30) and (79.47±10.78)% (n=53), respectively, while the plasma vWF-cp activity in 5 patients with TTP was markedly decreased [(21.83±19.98)%, P<0.001]. The unusually large vWF multimers were observed in two plasma samples of the patients with TTP. Although the vWF-cp activities in patients with benign and malignant tumors were also decreased (P<0.03 and P<0.001, respectively), they were relatively high in comparison with that of TTP patients (P<0.001).Conclusion Measurement of the vWF-cp activity using R-CBA is a simple and rapid method for diagnosing TTP. The vWF-cp activity in patients with TTP was markedly lower than those of patients with tumors.
- [1]J.-D. Studt,M. Böhm,U. Budde,etc.Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods[J].2003,1(9).
- [2]H M, Tsai.High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura.[J].2000,65(3).
- [3]Z M, Ruggeri,T S, Zimmerman.The complex multimeric composition of factor VIII/von Willebrand factor.[J].1981,57.
- [4]H M, Tsai,E C, Lian.Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.[J].1998,339.
- [5]Joel L, Moake.Thrombotic microangiopathies.[J].2002,347(8).
- [6]Decaudin D,Blot E,Bardier A,etc.Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency.[J].2002,106(2).
- [7]Lammle B,Furlan M.Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.[J].2002,28(2).
- [8]Fujikawa K,Chung D,Takayama TK,etc.Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura.[J].2001,276(44).
- [9]G G, Levy,W C, Nichols,E C, Lian,etc.Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.[J].2001,413(6855).
- [10]M, Furlan,R, Robles,M, Galbusera,etc.von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.[J].1998,339.
- [11]Ruggeri ZM.Old concepts and new developments in the study of platelet aggregation (comment)[J].2000,105(6).
- [12]Mannucci PM,Karimi M,Canciani MT,etc.Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease).[J].2003,88(4).
- [13]L, Oleksowicz,N, Bhagwati,M, DeLeon-Fernandez.Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies.[J].1999,59.